Mass Casualty Management System (DIORAMA-II)

大规模伤亡管理系统 (DIORAMA-II)

基本信息

  • 批准号:
    8223041
  • 负责人:
  • 金额:
    $ 39.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-30 至 2016-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The proposed DIORAMA-II system supports real-time assessment of a disaster site in terms of the victims' location and severity of injuries as well as the location of rescue personnel and resources. This application builds on a successfully completed R21 exploratory grant. The primary measurable outcomes of this system are: significant reduction in evacuation time of victims from the disaster site (average of 50% reduction in evacuation time compared to paper triage systems), 100% evacuation completeness of all triaged victims, and 100% geographical identification/verification of all triaged victims upon first responder triage. The first two outcomes correlate directly to reduced victims' mortality and the third is currently an unmet need in the disaster response discipline. The secondary outcomes are: enable the rescue personnel to treat the most critically injured victims first, improved response and management of medical rescue operations by assigning resources to the zones in most need, provision of seamless documentation of the rescue operations, enable post forensic analysis of the incident and rescue operations, provides data valuable to EMT training purposes, enable the hospitals to prepare for the arrival of patients, thus improving hospitals' utilization. This proposal is a joint collaboration between the University of Massachusetts, Amherst with an internationally team of leaders with recognized expertise in systems, software and hardware, Boston EMS which will provide the subject matter expertise and participate in our proposed trials, consultants such as the Director of the Division of Disaster Medicine at Beth Israel Deaconess Medical Center and a faculty member of Harvard Medical School, Medical Director of the Emergency Preparedness and Response Program at the Massachusetts Department of Public Health and the Massachusetts State EMS Medical Director, and advisory board which includes chief of Boston EMS that leads a 400-person department, president of the International Association of EMS Chiefs , the editor-in-chief of the Journal of Emergency Medical Services and also editorial director for all Elsevier Public Safety publications, former FEMA's Director of the Office of National Capital Region Coordination. We are confident that with the help of this internationally and nationally recognized team of leaders, innovative technology and very encouraging preliminary results obtained during the R21, we have very high chances of successfully completing these aims. This team of professionals will also advocate for the DIORAMA-II system to become a standard tool for disaster management.
描述(由申请人提供): 拟议的Diorama-II系统支持根据受害者的位置和受伤程度以及救援人员和资源的位置对受灾地点进行实时评估。此应用程序基于成功完成的R21探索性拨款。该系统的主要可衡量结果是:灾民从灾难现场的疏散时间显著减少(与纸质分诊系统相比,平均减少50%的疏散时间),所有分诊的受害者的疏散完成率为100%,在第一反应人员分诊时,所有分诊的受害者的地理识别/核实程度为100%。前两个结果直接关系到受害者死亡率的降低,第三个结果目前是灾害应对纪律中尚未得到满足的需要。次要结果是:使救援人员能够首先治疗最严重的伤者,通过将资源分配到最需要的地区来改进医疗救援行动的反应和管理,提供救援行动的无缝文件,能够对事件和救援行动进行法医后分析,提供对急救人员培训目的有价值的数据,使医院能够为病人的到来做好准备,从而提高医院的利用率。 这项提案是由马萨诸塞州大学、阿默斯特大学与具有公认的系统、软件和硬件专业知识的国际领导者团队、波士顿EMS(将提供主题专业知识并参与我们拟议的试验)、顾问(如贝丝以色列女执事医学中心灾难医学部主任和哈佛医学院教职员工、马萨诸塞州公共卫生部应急准备和响应计划医务主任和马萨诸塞州EMS医务主任)以及顾问委员会(包括领导400人部门的波士顿EMS负责人、国际EMS负责人协会主席)共同合作的项目。他是《紧急医疗服务杂志》的主编,也是所有爱思唯尔公共安全出版物的编辑总监,前联邦应急管理局国家首都地区协调办公室主任。 我们相信,在国际和国内公认的领导团队、创新技术和在R21期间取得的非常令人鼓舞的初步成果的帮助下,我们有很高的机会成功实现这些目标。这支专业团队还将倡导DIORAMA-II系统成为灾害管理的标准工具。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Aura Ganz其他文献

Aura Ganz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Aura Ganz', 18)}}的其他基金

Mass Casualty Management System (DIORAMA-II)
大规模伤亡管理系统 (DIORAMA-II)
  • 批准号:
    8722623
  • 财政年份:
    2012
  • 资助金额:
    $ 39.06万
  • 项目类别:
Mass Casualty Management System (DIORAMA-II)
大规模伤亡管理系统 (DIORAMA-II)
  • 批准号:
    8927395
  • 财政年份:
    2012
  • 资助金额:
    $ 39.06万
  • 项目类别:
PERCEPT: RFID-Enabled Smart Pavement Technology For Visually Impaired
PERCEPT:针对视障人士的 RFID 智能路面技术
  • 批准号:
    7990333
  • 财政年份:
    2010
  • 资助金额:
    $ 39.06万
  • 项目类别:
PERCEPT: RFID-Enabled Smart Pavement Technology For Visually Impaired
PERCEPT:针对视障人士的 RFID 智能路面技术
  • 批准号:
    8139782
  • 财政年份:
    2010
  • 资助金额:
    $ 39.06万
  • 项目类别:
DIORAMA: Dynamic Information Collection and Resource Tracking Architecture
DIORAMA:动态信息收集和资源跟踪架构
  • 批准号:
    7389802
  • 财政年份:
    2008
  • 资助金额:
    $ 39.06万
  • 项目类别:
DIORAMA: Dynamic Information Collection and Resource Tracking Architecture
DIORAMA:动态信息收集和资源跟踪架构
  • 批准号:
    8066225
  • 财政年份:
    2008
  • 资助金额:
    $ 39.06万
  • 项目类别:
DIORAMA: Dynamic Information Collection and Resource Tracking Architecture
DIORAMA:动态信息收集和资源跟踪架构
  • 批准号:
    7632263
  • 财政年份:
    2008
  • 资助金额:
    $ 39.06万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 39.06万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 39.06万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 39.06万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 39.06万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 39.06万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 39.06万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 39.06万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 39.06万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 39.06万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 39.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了